Sources: David Sacks told President Trump that federal reviews of AI models before release would slow down innovation and hurt the US in its AI race with China
But during a conversation with Trump, Sacks told the president that companies were already cooperating, and that having …
Context & Ripple Effects
The administration’s AI policy debate has already centered on avoiding a fragmented state-by-state compliance regime. Related coverage describes Sacks advocating an executive order to curb state AI laws while the White House pursued a common federal oversight standard with Congress.
The newly discussed working group on AI oversight put pre-release model vetting on the table. Sacks’ reported intervention sharpens the administration’s apparent distinction between coordination on AI policy and a centralized pre-approval system; Krishnan has separately said Trump would not support an “FDA for AI.”
First-order effects
- Federal pre-release reviews of AI models are less likely to become the administration’s preferred oversight mechanism if Sacks’ competitiveness argument carries weight with Trump.
- AI developers would retain more discretion over release timing, rather than preparing models for a centralized federal clearance process.
Second-order effects
- The policy debate shifts toward lighter-touch federal standards and away from model-by-model gatekeeping, while preserving the administration’s parallel push to reduce state-level compliance burdens.
- Developers and lobbyists seeking nationally uniform rules gain a clearer argument against both state fragmentation and federal pre-approval, potentially complicating efforts to build a bipartisan oversight compromise.
Third-order effects
- If this approach holds, US AI governance could develop around federal preemption and post-release accountability rather than a regulator that approves frontier models before deployment.
- That would make the competitiveness-versus-safety tradeoff the central fault line in US AI policy, with the durability of any federal standard dependent on whether Congress can convert executive-branch preferences into legislation.
The trend: This is one data point in the Trump administration’s move toward nationally uniform, innovation-first AI governance rather than centralized pre-release regulation.